Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis
Clinical trial NCT00447915 · COMPLETED
Trial details
- NCT number
- NCT00447915
- Sponsor
- Chugai Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2011-08-01
- Enrollment
- 1265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.